★ WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES ★
VOL. XCIV, NO. 247
Stock Profile
Intuitive Surgical, Inc. (ISRG) Moat Analysis
Intuitive Surgical, Inc.
ISRG · The Nasdaq Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Request update
Spot something outdated? Send a quick note and source so we can refresh this profile.
Overview
Intuitive Surgical sells da Vinci and Ion robotic surgery systems, then earns recurring revenue from instruments, accessories and service. In Q2 2026, instruments and accessories supplied 60.0% of revenue, systems 23.7% and service 16.3%. The strongest moat is the proprietary installed-base consumables model, reinforced by surgeon and operating-room training and a global field-service network. Combined procedures grew 16%, the installed base reached 11,710 da Vinci and 1,096 Ion systems, and recurring revenue was 85% of the quarter. These advantages face credible limits: hospitals negotiate large contracts, instruments can be reprocessed, staff can train on rival systems, and Medtronic, Johnson & Johnson and Chinese vendors are investing heavily. Supplier concentration, tariffs, service regulation and hospital capital budgets remain material risks.
Primary segment
Instruments and Accessories
Market structure
Monopoly
Market share
—
HHI: —
Coverage
3 segments · 8 tags
Updated 2026-08-23
Segments
Systems
Robotic-assisted surgical systems for minimally invasive soft-tissue and endoluminal procedures
Revenue
23.7%
Structure
Quasi-Monopoly
Pricing
moderate
Share
—
Peers
Instruments and Accessories
Proprietary robotic surgery instruments, accessories, and consumables used per procedure on the da Vinci (and Ion) installed base
Revenue
60%
Structure
Monopoly
Pricing
strong
Share
—
Peers
Services
Service contracts, maintenance, and uptime and monitoring services for the da Vinci and Ion installed base
Revenue
16.3%
Structure
Monopoly
Pricing
moderate
Share
—
Peers
Moat Claims
Systems
Robotic-assisted surgical systems for minimally invasive soft-tissue and endoluminal procedures
Revenue share computed from Q2 2026 disaggregated revenue: Systems $685.0M of total $2.8923B. Intuitive placed 468 da Vinci and 55 Ion systems; 254 da Vinci placements were operating leases, including 131 usage-based leases.
Training Org Change Costs
Demand
Training Org Change Costs
Strength
Durability
Confidence
Evidence
Role-based training pathways and simulation tools (with tracking) raise organizational adoption and switching costs for surgeons, residents, and OR teams.
Training Org Change Costs moat: definition, examples, and stocks
Erosion risks
- Surgeons increasingly train on multiple vendors (multi-homing)
- Standardized credentialing and third-party training reduces differentiation
- Remote proctoring lowers the friction of switching platforms
Leading indicators
- Utilization of Intuitive Learning / SimNow platforms
- Adoption speed for new system generations at existing sites
- Share of procedures from newly trained surgeons
Counterarguments
- Hospitals regularly retrain staff and may switch if ROI is compelling
- Newer surgeons may be less loyal to a single platform over their careers
Instruments and Accessories
Proprietary robotic surgery instruments, accessories, and consumables used per procedure on the da Vinci (and Ion) installed base
Revenue share computed from Q2 2026 disaggregated revenue: Instruments and accessories $1.7349B of total $2.8923B. At quarter-end, the installed base was 11,710 da Vinci systems and 1,096 Ion systems.
Installed Base Consumables
Demand
Installed Base Consumables
Strength
Durability
Confidence
Evidence
Per-procedure instruments and accessories are largely tied to Intuitive platforms and are limited-use, creating a durable recurring revenue stream proportional to procedure volume.
Installed Base Consumables moat: definition, examples, and stocks
Erosion risks
- Third-party reprocessing and remanufacturing reduces instrument replacement rates
- Procedure growth slows or shifts to alternative modalities
- Pricing pressure from large IDNs and GPOs and hospital cost containment
Leading indicators
- Instruments and accessories revenue per procedure
- Global procedure growth and procedure mix by specialty
- Penetration of reprocessed and third-party instruments (where permitted)
Counterarguments
- Hospitals can push back on consumables pricing and extend life via reprocessing
- If competing platforms gain placements, consumables attach can shift away over time
Services
Service contracts, maintenance, and uptime and monitoring services for the da Vinci and Ion installed base
Revenue share computed from Q2 2026 disaggregated revenue: Services $472.4M of total $2.8923B. Intuitive typically enters service contracts when systems are sold or leased, and system sales generally include a five-year service period.
Service Field Network
Supply
Service Field Network
Strength
Durability
Confidence
Evidence
A dense field service network plus 24/7 support and proactive monitoring supports high uptime and reinforces service renewals for mission-critical OR equipment.
Service Field Network moat: definition, examples, and stocks
Erosion risks
- Third-party service providers compete on price or coverage
- Right-to-repair and parts access regulation expands
- Cybersecurity incidents disrupt connected monitoring
Leading indicators
- Service contract renewal and attach rates
- System uptime and unplanned downtime incidence
- Service gross margin and cost-to-serve trends
Counterarguments
- Large hospital systems may build in-house biomedical engineering capacity or use third parties
- Competitors can bundle aggressive service terms with new system placements
Evidence
Intuitive provides a progressive learning journey
Shows structured training offerings embedded in adoption.
The SimNow online connection drives real-time simulation performance tracking
Training with measurable progression and analytics increases organizational stickiness.
between $900 and $3,700 of instruments and accessories revenue per surgical procedure
Direct evidence that each procedure drives recurring consumables revenue.
Total recurring revenue $ 2,469.1
Q2 2026 recurring revenue remained 85% of total revenue, supporting installed-base monetization.
We have a network of field service engineers across the U.S., Canada, Europe, and Asia
Direct evidence of service footprint and uptime-oriented support model.
Risks & Indicators
Erosion risks
- Surgeons increasingly train on multiple vendors (multi-homing)
- Standardized credentialing and third-party training reduces differentiation
- Remote proctoring lowers the friction of switching platforms
- Third-party reprocessing and remanufacturing reduces instrument replacement rates
- Procedure growth slows or shifts to alternative modalities
- Pricing pressure from large IDNs and GPOs and hospital cost containment
Leading indicators
- Utilization of Intuitive Learning / SimNow platforms
- Adoption speed for new system generations at existing sites
- Share of procedures from newly trained surgeons
- Instruments and accessories revenue per procedure
- Global procedure growth and procedure mix by specialty
- Penetration of reprocessed and third-party instruments (where permitted)
Research ISRG elsewhere
Keep the research going
More Rankings & Systems
Quality Stocks
High quality stocks ranked by profitability, margins, free cash flow quality, durability, solvency, and accounting...
Stock rankingUndervalued Stocks
Undervalued stocks from the NA & Europe universe, ranked with a multi-measure value system and quality controls.
Stock rankingDividend Stocks
Dividend stocks ranked by payout yield, payout sustainability, dividend growth, quality, balance-sheet safety, risk...
Stock rankingDefensive Stocks
Defensive stocks ranked by low volatility, low beta, intermediate momentum, durable profitability, balance sheet...
Stock rankingMomentum Stocks
Momentum stocks ranked by total return momentum, relative momentum, trend confirmation, and risk-adjusted momentum...
Stock rankingConviction 10
A concentrated 10-stock strategy from the NA & Europe universe, ranked across quality, value, growth, momentum, and...
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.